Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 03, 2026 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance

IRVINE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of...
May 27, 2026 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Appoints Edward Sarnowski as Chief Technology Officer

IRVINE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of...
May 20, 2026 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs

IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of...
May 12, 2026 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Appoints Dave Haan as Vice President of Clinical Affairs

IRVINE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of...
April 01, 2026 08:00 ET | Source: JenaValve Technology, Inc.

JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)

IRVINE, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the successful first...
March 18, 2026 08:00 ET | Source: JenaValve Technology, Inc.

JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System — the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR) in the United States

IRVINE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food...
January 29, 2026 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Appoints John Molyneux to Vice President of Operations

IRVINE, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the appointment of...
November 24, 2025 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Announces New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves

IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from an...
November 17, 2025 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Announces 1,000th Case with the Trilogy™ Transcatheter Heart Valve (THV) System

IRVINE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of its...
November 10, 2025 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025

IRVINE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the...